James Reagan
Analyst · Cowen and Company
Thank you, Roger, and thanks, everyone, for joining us today. We're pleased with our full year 2018 results, and I'll start by highlighting a few of our accomplishments for the fourth quarter and the full year. Fourth quarter revenues increased 5.2% from the prior year and 2.8% sequentially, our third consecutive quarter of growth and another proof point in our growth trajectory. In 2018, our adjusted EBITDA margins of 10.4% again exceeded our long-term target of 10% or higher. Fourth quarter margins were 9.7%, in line with our expectations and reflect typical seasonality in the margin profile due to a higher proportion of materials revenues compared with other quarters. This strong operational performance, coupled with lower-than-expected tax rate, drove a non-GAAP diluted EPS of $1.10 in the quarter. Non-GAAP diluted EPS for the year was $4.38, at the upper end of our guidance range. Operating cash flows for the full year of $768 million increased 46% from the prior year and resulted in 104% free cash flow conversion of non-GAAP net income in line with our long-term goal. This slight miss versus our guidance target was driven by unexpected timing slips in the fourth quarter due to year-end payment system transitions at a couple of our key customers. During the fourth quarter, we continue to monetize our balance sheet by selling our old headquarters building in San Diego for net proceeds of $79 million. The cash proceeds from this were received and recognized in 2 tranches: $14 million in financing inflows in Q4 of '18 and $65 million in investing inflows that will be in Q1 of 2019. In addition, just after the close of the year, we also closed on the sale of the old IS&GS headquarters in Gaithersburg for $31 million. Proceeds will be recognized as a cash flow from investing item during the first quarter of 2019, and these two transactions are an extension of our focus on monetizing noncore assets and increasing our return on invested capital. Now let me share some comments on our segment results. Revenues in the Defense Solutions segment increased 3.6% in the fourth quarter compared to the prior year period, driving the third consecutive quarter of growth in the business. This growth largely reflects new program activity that expands our revenue base. Non-GAAP operating margins in our Defense Solutions segment decreased 160 basis points from the prior year quarter to 7.7%, reflecting a lower level of net profit write-ups. As a reminder, there's typically a fair amount of variability in the quarterly timing of profit write-ups. For the full year, the segment's margins were 8.4%, flat with the prior year, reflecting a similar level of profit write-ups. Awards activity was a highlight in the Defense Solutions segment. Net bookings were over $7 billion in 2018, a 56% increase from 2017. Book-to-bill for the year was 1.4, a substantial increase over the prior year level of 0.9. In our Civil segment, the new program wins and on-contract growth contributed notably to fourth quarter results, driving revenue growth of 3.6% over the prior year period. The start-up of new programs was the primary cause of the roughly 100 basis point decline in non-GAAP operating margins to 9.7%. Overall, we are pleased in the growth in this business and are confident in our ability to drive margins higher over time in this segment. Bookings in our Civil business increased in the fourth quarter with roughly $1 billion in net bookings, which resulted in a 1.1 book-to-bill for the quarter and 1.0 for the year. Turning now to our Health segment. Fourth quarter results were again very strong across all metrics: revenue growth, margins and bookings. Revenue grew nearly 13% over the prior year and roughly 12% sequentially. This growth largely reflects the slippage of some revenues from the third quarter into the fourth quarter as we discussed in our third quarter call. Margins in our Health business expanded in tandem with the revenue growth. Non-GAAP operating income margin of 16.1% in the fourth quarter increased more than 400 basis points from the prior year and 190 basis points sequentially. For the full year, non-GAAP operating margins of 15.2% increased 30 basis points from the prior year. The margin expansion reflects a greater mix of on-contract growth in certain quick-turn, fixed-unit-price contracts. The Health segment also had a very strong year in awards activity with full year net bookings of $3.2 billion, roughly 75% higher than the prior year level, resulting in a 1.7x book-to-bill for the year. During the fourth quarter, we booked $1.1 billion into backlog in the Health segment, resulting in a book-to-bill of 2.2. Overall, all of our businesses demonstrated solid progress in the fourth quarter towards our growth targets, and we expect all segments to grow in 2019. Now before I talk about 2019 guidance, I want to comment on the government shutdown and its impacts to our business. For fiscal year 2018, the shutdown was in effect for 4 working days at the very end of the year, where we typically see heavy vacation usage, so there was minimal impact to our business. The shutdown did, however, force the closure of the Committee on Foreign Investments in the United States, or CFIUS, which was the last approval needed to allow for the closure of our commercial cyber sale. We continue to work the process, and we expect that deal to close within the first quarter of 2019. For 2019, the shutdown impacts to our business are also relatively immaterial. But given the volume of questions we've received on this, I'll provide some context. First, we estimate our aggregate revenue impact resulting from the shutdown to be approximately $11 million. This effect is largely isolated to our Civil segment, where some of our work for the FAA and the Department of Homeland Security were deemed nonessential, causing us to furlough some employees. We realize the effect that this had on those employees, and it was not a step taken lightly. We may be able to recover some of this revenue loss throughout the year, but it is too early to estimate any recovery now. The shutdown also caused some delays in the billing and collection cycle as well as with award decisions. But these effects are more timing related, and we don't expect any permanent impacts to our business from those delays. Now on to our guidance for 2019. We expect revenue in the range of $10.5 billion to $10.9 billion, reflecting growth of 3% to 7% from 2018. We expect 2019 to be a year in which we will exceed our 3% long-term revenue target growth due to the strength of our backlog entering the year and our focus on driving on-contract growth and winning new business throughout the year. Although we do not guide on a quarterly basis, I would like to provide some context on the quarterly phasing of revenues for the year and particularly for the first quarter. Similar to 2018, we expect revenues to build sequentially throughout the year, starting from a low point in the first quarter. Historically, Q1 revenues declined sequentially due to the lower level of material volumes compared to Q4. This year, however, we expect a greater sequential decline in the high single-digit range due to the combined effects of low materials buying in the first quarter, program transitions in our Health segment and the shutdown. From the first quarter low, however, we expect revenues to grow sequentially throughout the year and to drive to our full year revenue guidance. We expect adjusted EBITDA margins of 9.9% to 10.1% for the year, a slight decrease compared to 2018. And as we've said in the past, there is a trade-off between margin and revenue growth, and the ramp-up of our new awards will drive slightly lower margin levels in the near term. We expect non-GAAP EPS between $4.25 and $4.60. We expect operating cash flow of at least $725 million, a slight increase from 2018 levels after adjusting for the interest rate swap monetization and the usually low cash tax rate we experienced in 2018. Following the fourth quarter sale of our San Diego building, we will move into the more material phase of our real estate consolidation activities in 2019. We will continue to streamline our footprint and reduce owned facilities, allowing us to work more efficiently and increase the level of collaboration across our functions. As a result of these actions, we expect a lot of moving parts to the different components of our cash flow statement this year. So we've added a slide, Slide 10, in our earnings deck, which is available on our website, to help you with some of the details. Some of the real estate action increased CapEx and, therefore, reduced the free cash flow metric, while others result in inflows in cash in investing and financing activities. At the end of the day, the net of all of our balance sheet monetization activities and our real estate investments will yield a positive cash inflow for the company, and we will continue to deploy our excess cash from those transactions consistent with our stated capital deployment plan. All that said, we expect 2019 capital expenditures of between $135 million and $140 million. Roughly $60 million of that is related to real estate investments and leasehold improvements, which will drive better asset utilization. As we've said earlier, between the San Diego and Gaithersburg real estate sales, we have already closed on transactions that will drive $95 million inflows to cash from investing in the first quarter. These inflows will more than offset the onetime $60 million CapEx item that I referred to earlier. Beyond leaning out our real estate portfolio, we will continue to look for opportunities to monetize the balance sheet, which increases our flexibility and drive value for our shareholders. Now a couple of other comments to help you with modeling 2019. We expect net interest expense between $135 million to $140 million and a non-GAAP tax rate between 23% and 24%. To wrap up, we closed the year on strong footing. We generated over 3/4 of $1 billion of cash from operations. Our margins were again over target for the second year in a row, and we exited the year with a revenue growth rate of 5.2% and record backlog. We remain focused on continuing this momentum into 2019 by driving profitable growth and generating cash to drive long-term value. With that, I'll turn the call over to Kevin, so we can take some questions.